Another meta-analysis included three cohort studies for 1100 healthy women with BRCA1 and BRCA2 P/LP germline variants who underwent risk-reducing bilateral salpingo-oophorectomy before the onset of natural menopause to assess the association between breast cancer incidence and HRT. The gene discussed is BRCA2; the disease is breast cancer.